Apoptotic cells trigger a membrane-initiated pathway to increase ABCA1

Journal of Clinical Investigation

Volumn 125, Issue 7, 2015, Pages 2748-2758

  Fond, Aaron M ^a   Lee, Chang Sup ^a   Schulman, Ira G ^b   Kiss, Robert S ^c,d   Ravichandran, Kodi S ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ANGIOGENESIS INHIBITOR; BRAIN SPECIFIC ANGIOGENESIS INHIBITOR 1; CELL PROTEIN; CHOLESTEROL; LIPID; LIVER X RECEPTOR; MESSENGER RNA; PHOSPHATIDYLSERINE; RAC1 PROTEIN; UNCLASSIFIED DRUG; ABCA1 PROTEIN, MOUSE; ANGIOGENIC PROTEIN; BAI1 PROTEIN, MOUSE; ELMO1 PROTEIN, MOUSE; NEUROPEPTIDE; ORPHAN NUCLEAR RECEPTOR; RAC1 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; AORTA ROOT; APOPTOSIS; ARTICLE; CELL COUNT; CELL FUNCTION; CELL MEMBRANE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE OVEREXPRESSION; INTRACELLULAR SIGNALING; LIPID ANALYSIS; LIPID DIET; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTE; PRIORITY JOURNAL; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; DEFICIENCY; FEMALE; GENETICS; HUMAN; JURKAT CELL LINE; KNOCKOUT MOUSE; LIPID METABOLISM; MACROPHAGE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANGIOGENIC PROTEINS; ANIMALS; APOPTOSIS; ATP BINDING CASSETTE TRANSPORTER 1; CELL MEMBRANE; CHOLESTEROL; FEMALE; HUMANS; JURKAT CELLS; LIPID METABOLISM; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEUROPEPTIDES; ORPHAN NUCLEAR RECEPTORS; RAC1 GTP-BINDING PROTEIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84936765944     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI80300     Document Type: Article

References (59)

1. Nagata S, Hanayama R, Kawane K. Autoimmunity and the clearance of dead cells. Cell. 2010;140(5):619-630.
2. Janssen WJ, Henson PM. Cellular regulation of the inflammatory response. Toxicol Pathol. 2012;40(2):166-173.
3. Gregory CD, Pound JD. Microenvironmental influences of apoptosis in vivo and in vitro. Apoptosis. 2010;15(9):1029-1049.
4. Han CZ, Ravichandran KS. Metabolic connections during apoptotic cell engulfment. Cell. 2011;147(7):1442-1445.
5. Green DR, Galluzzi L, Kroemer G. Metabolic control of cell death. Science. 2014;345(6203):1250256.
6. Phillips MC. Molecular mechanisms of cellular cholesterol efflux. J Biol Chem. 2014;289(35):24020-24029.
7. Curtiss LK, Kubo N, Schiller NK, Boisvert WA. Participation of innate and acquired immunity in atherosclerosis. Immunol Res. 2000;21(2):167-176.
8. Oram JF. Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1. Trends Mol Med. 2002;8(4):168-173.
9. Ravichandran KS, Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol. 2007;7(12):964-974.
10. Wang M-D, Franklin V, Marcel YL. In vivo reverse cholesterol transport from macrophages lacking ABCA1 expression is impaired. Arterioscler Thromb Vasc Biol. 2007;27(8):1837-1842.
11. Tarling EJ, de Aguiar Vallim TQ, Edwards PA. Role of ABC transporters in lipid transport and human disease. Trends Endocrinol Metab. 2013;24(7):342-350.
12. Westerterp M, Bochem AE, Yvan-Charvet L, Murphy AJ, Wang N, Tall AR. ATP-binding cassette transporters, atherosclerosis, and inflammation. Circ Res. 2014;114(1):157-170.
13. Tall AR. Cholesterol efflux pathways and other potential mechanisms involved in the atheroprotective effect of high density lipoproteins. J Intern Med. 2008;263(3):256-273.
14. Van Eck M. ATP-binding cassette transporter A1: key player in cardiovascular and metabolic disease at local and systemic level. Curr Opin Lipidol. 2014;25(4):297-303.
15. Marcel YL, Ouimet M, Wang M-D. Regulation of cholesterol efflux from macrophages. Curr Opin Lipidol. 2008;19(5):455-461.
16. Maxfield FR, Tabas I. Role of cholesterol and lipid organization in disease. Nature. 2005;438(7068):612-621.
17. Go AS, et al. Heart disease and stroke statistics-2014 update: A report from the American Heart Association. Circulation. 2014;129(3):e28-e292.
18. Gerrity RG, Naito HK, Richardson M, Schwartz CJ. Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages. Am J Pathol. 1979;95(3):775-792.
19. Fenyo IM, Gafencu AV. The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis. Immunobiology. 2013;218(11):1376-1384.
20. Shibata N, Glass CK. Regulation of macrophage function in inflammation and atherosclerosis. J Lipid Res. 2009;50(suppl):S277-S281.
21. Koltsova EK, Hedrick CC, Ley K. Myeloid cells in atherosclerosis: A delicate balance of anti-inflammatory and proinflammatory mechanisms. Current Opinion in Lipidology. 2013;24(5):371-380.
22. Thorp E, Subramanian M, Tabas I. The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis. Eur J Immunol. 2011;41(9):2515-2518.
23. Tarling EJ, Edwards PA. Dancing with the sterols: critical roles for ABCG1, ABCA1, miRNAs, and nuclear and cell surface receptors in controlling cellular sterol homeostasis. Biochim Biophys Acta. 2012;1821(3):386-395.
24. Brunham LR, Singaraja RR, Hayden MR. Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis. Annu Rev Nutr. 2006;26:105-129.
25. Oram JF, Heinecke JW. ATP-binding cassette transporter A1: A cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev. 2005;85(4):1343-1372.
26. Assmann G, von Eckardstein A, Brewer HB. Familial high density lipoprotein deficiency: Tangier disease. In Scriver CR, ed. The Metabolic and Molecular Basis of Inherited Disease. New York, New York, USA: McGraw-Hill;1995:2053-2072.
27. Moore KJ, Fisher EA. High-density lipoproteins put out the fire. Cell Metab. 2014;19(2):175-176.
28. Kiss RS, Elliott MR, Ma Z, Marcel YL, Ravichandran KS. Apoptotic cells induce a phosphatidylserine-dependent homeostatic response from phagocytes. Curr Biol. 2006;16(22):2252-2258.
29. Annema W, Tietge UJ. Regulation of reverse cholesterol transport-A comprehensive appraisal of available animal studies. Nutr Metab (Lond). 2012;9(1):25.
30. Pattabiraman G, Lidstone EA, Palasiewicz K, Cunningham BT, Ucker DS. Recognition of apoptotic cells by viable cells is specific, ubiquitous, and species independent: analysis using photonic crystal biosensors. Mol Biol Cell. 2014;25(11):1704-1714.
31. Tóth B, et al. Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells. J Immunol. 2009;182(4):2084-2092.
32. Hong C, Tontonoz P. Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat Rev Drug Discov. 2014;13(6):433-444.
33. Venkateswaran A, et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A. 2000;97(22):12097-12102.
34. A-Gonzalez N, Hidalgo A. Nuclear receptors and clearance of apoptotic cells: stimulating the macrophage's appetite. Front Immunol. 2014;5:211.
35. A-Gonzalez N, et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity. 2009;31(2):245-258.
36. Wagner BL, et al. Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol Cell Biol. 2003;23(16):5780-5789.
37. Zuercher WJ, et al. Discovery of tertiary sulfonamides as potent liver X receptor antagonists. J Med Chem. 2010;53(8):3412-3416.
38. Hochreiter-Hufford AE, et al. Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion. Nature. 2013;97(7448):263-267.
39. Rodriguez-Manzanet R, et al. T and B cell hyperactivity and autoimmunity associated with nichespecific defects in apoptotic body clearance in TIM-4-deficient mice. Proc Natl Acad Sci U S A. 2010;107(19):8706-8711.
40. Park D, Hochreiter-Hufford A, Ravichandran KS. The phosphatidylserine receptor TIM-4 does not mediate direct signaling. Curr Biol. 2009;19(4):346-351.
41. Brugnera E, et al. Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex. Nat Cell Biol. 2002;4(8):574-582.
42. Kinchen JM, et al. Two pathways converge at CED-10 to mediate actin rearrangement and corpse removal in C. elegans. Nature. 2005;434(7029):93-99.
43. Elliott MR, et al. Unexpected requirement for ELMO1 in clearance of apoptotic germ cells in vivo. Nature. 2010;467(7313):333-337.
44. Juncadella IJ, et al. Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation. Nature. 2013;493(7433):547-551.
45. Brooks-Wilson A, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet. 1999;22(4):336-345.
46. Vaisman BL, et al. Endothelial expression of human ABCA1 in mice increases plasma HDL cholesterol and reduces diet-induced atherosclerosis. J Lipid Research. 2012;53(1):158-167.
47. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest. 1993;92(2):883-893.
48. van Eck M, et al. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci U S A. 2002;99(9):6298-6303.
49. Aiello RJ, et al. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol. 2002;22(4):630-637.
50. Meurs I, et al. Effects of deletion of macrophage ABCA7 on lipid metabolism and the development of atherosclerosis in the presence and absence of ABCA1. PLoS ONE. 2012;7(3):e30984.
51. Bi X, et al. Myeloid cell-specific ATP-binding cassette transporter A1 deletion has minimal impact on atherogenesis in atherogenic diet-fed low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol. 2014;34(9):1888-1899.
52. Korns D, Frasch SC, Fernandez-Boyanapalli R, Henson PM, Bratton DL. Modulation of macrophage efferocytosis in inflammation. Front Immun. 2011;2:57.
53. Rader DJ. Illuminating HDL-is it still a viable therapeutic target? N Engl J Med. 2007;357(21):2180-2183.
54. Ono K. Current concept of reverse cholesterol transport and novel strategy for atheroprotection. J Cardiol. 2012;60(5):339-343.
55. Uppal H, et al. Activation of LXRs prevents bile acid toxicity and cholestasis in female mice. Hepatology. 2007;45(2):422-432.
56. Glogauer M, et al. Rac1 deletion in mouse neutrophils has selective effects on neutrophil functions. J Immunol. 2003;170(11):5652-5657.
57. Su HP, et al. Identification and characterization of a dimerization domain in CED-6, an adapter protein involved in engulfment of apoptotic cells. J Biol Chem. 2000;275(13):9542-9549.
58. Park D, et al. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/ Rac module. Nature. 2007;450(7168):430-434.
59. Carpenter AE, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7(10):R100.